Digital Health Startups

Cuvris builds specialty-focused AI agents that automate healthcare practice operations, including referral triage, patient intake, qualification, scheduling, and clinical documentation. It serves care teams and medical practices to reduce administrative workload, improve chart accuracy, and lower claim denials.

1 investor

CVAid develops an AI-powered stroke triage platform using standard smartphones and mobile applications to enable early diagnosis, in-hospital process management, and post-discharge follow-up. The company serves healthcare providers and stroke patients globally.

1 investor

CVS Health is a health care company that connects people to care through insurance plans, retail and specialty pharmacies, prescription delivery, walk-in appointments, and a pharmacy benefit manager. It serves individuals and families in the United States, offering services to manage chronic conditions, mental and physical well-being, and access to affordable medications.

1 investor

Cyclerion is a biopharmaceutical company developing therapeutics for neuropsychiatric diseases, with a lead candidate (CYC-126) for treatment-resistant depression that pairs anesthetic agents with a personalized biofeedback-driven device. It targets patients, providers, and health systems seeking individualized mental health treatment.

1 investor

Cyclops Medtech develops a portfolio of vestibular diagnostic and therapy products—including videonystagmography (VNG/VOG), video head impulse testing (vHIT), dynamic visual acuity, stabilometry platforms, VR-based vestibular rehabilitation, and a smart balance board—to diagnose and treat dizziness and balance disorders. Its tools serve clinicians across neurotology, neurology, physiotherapy, audiology, and ophthalmology.

1 investor

Cyrano Therapeutics is a clinical-stage regenerative medicine company developing CYR-064, a nasal therapy for post-viral smell loss (hyposmia) and associated loss of taste. It serves patients with anosmia and is advancing its lead candidate through clinical trials toward Phase 3.

1 investor

Cyrebro Neurosignals develops a neurotechnology platform using EEG and AI to analyze brain activity in real time, providing digital neuromarkers for healthcare applications and consumer product development. The platform serves healthcare professionals, clinical researchers, and consumer product companies in mental health, neurological treatment, and product optimization.

1 investor

CyrenCare provides digital patient intake software that captures clinical information through customizable forms and generates clinician-friendly reports for healthcare providers. The platform supports multilingual service delivery.

1 investor

Cytokinetics develops potential medicines for cardiovascular and neuromuscular diseases characterized by impaired muscle function. The company specializes in sarcomere-directed therapies targeting conditions involving muscle weakness, loss, and dysfunction.

1 investor

Cytura Therapeutics is a pharmaceutical company focused on drug discovery and development, with backing from academic research institutions and venture capital firms specializing in biotech and medtech investments.

1 investor

D2Type provides AI-enabled, lifestyle-first diabetes and cardiometabolic care delivered as between-visit clinical support, using proactive monitoring, early detection, and human clinical escalation to complement therapies like GLP-1s. It partners with health systems, employers, health plans, and clinicians to advance value-based care and reduce avoidable admissions and complications.

1 investor

dacadoo provides a digital health platform that scores individual health status and guides lifestyle choices, serving enterprises, insurers, and corporate wellness providers across 40 countries. The company uses AI and gamification to engage users in health improvement and support business decisions through health risk quantification.

1 investor

Daisies is a women's health telemedicine app in Mexico offering a membership that provides access to female doctors across 20+ specialties, including gynecology, psychology, nutrition, general health, and training. It provides on-demand video consultations, digital prescriptions, a shared encrypted medical record, and clinical self-assessments, available 24/7 via mobile.</parameter> <parameter name="hq_country">MX

1 investor

DalCor Pharmaceuticals is a biopharmaceutical company developing dalcetrapib, a pharmacogenetic precision medicine for cardiovascular disease that targets patients with the ADCY9 AA genotype. The drug is being evaluated in Phase 3 clinical trials to reduce fatal and non-fatal myocardial infarction in post-acute coronary syndrome patients.

1 investor

Motherbeing offers a women's health app that combines an AI assistant ("Daleela") for medically-verified health guidance, cycle and period tracking, remote consultations with specialists in gynecology, dermatology, nutrition, and sexual health, and expert-led educational video programs. It serves women seeking to understand and care for their bodies.

1 investor

Damae Medical develops deepLive, a non-invasive skin imaging system based on LC-OCT (Line-field Confocal Optical Coherence Tomography) that produces 3D histology-like and confocal-like images of skin tissue. The device is used by dermatologists to image and assess skin conditions including melanoma and carcinoma.

1 investor

Damora Therapeutics develops targeted monoclonal antibody therapies for rare blood disorders, specifically Essential Thrombocythemia and Myelofibrosis driven by mutant calreticulin mutations. The company is advancing novel subcutaneous biologics to treat approximately 42,000 U.S. patients with these myeloproliferative neoplasms.

1 investor

Dario provides digital tools and support to help people manage chronic conditions such as diabetes between provider visits. Its platform focuses on day-to-day health management for individuals with one or more chronic conditions, primarily in the U.S.

1 investor

Dart builds clinical AI tools that turn natural-language clinical objectives into validated models and decision logic for hospitals and health systems. Its platform supports perioperative and emergency operations, quality and patient safety, and post-acute settings such as hospice and home health.

1 investor

Data Dissect provides a configurable data capture platform for clinical registries and learning healthcare systems, serving clinicians, patients, hospitals, and the healthcare industry. Developed by surgeons and healthcare professionals, the platform integrates with existing repositories like EMRs and data lakes and includes a patient portal for longitudinal outcome tracking.

1 investor

DataBiologics provides a software platform that enables healthcare providers to collect and analyze patient-reported outcome data from regenerative medicine treatments. The platform helps orthobiologic practices personalize patient care and generate real-world evidence to support treatment adoption decisions.

1 investor

Datar Cancer Genetics provides cancer testing across the care continuum, using tissue profiling and non-invasive liquid biopsies to analyze molecular biomarkers for early detection, diagnosis, treatment selection, and recurrence monitoring. It offers comprehensive genomic profiling and chemosensitivity resistance testing to support personalized cancer therapies, operating clinical laboratories in Nashik, India and Guildford, UK.

1 investor

DataUnite operates a privacy-first data collaboration platform that lets biopharma companies and health systems securely access and share real-world patient data for research. It targets the healthcare and life sciences sector, using privacy-preserving technologies to enable data access without compromising patient privacy.

1 investor

Datica provides data integration and compliance tools for building healthcare applications in the cloud, including Datica Monitor, a SaaS product that uses APIs to assess the configuration and compliance state of cloud services. It serves healthcare developers and organizations working with cloud platforms such as AWS.

1 investor